GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (FRA:4QG) » Definitions » 6-1 Month Momentum %

PCI Biotech Holding ASA (FRA:4QG) 6-1 Month Momentum % : -36.82% (As of Dec. 14, 2024)


View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-14), PCI Biotech Holding ASA's 6-1 Month Momentum % is -36.82%.

The industry rank for PCI Biotech Holding ASA's 6-1 Month Momentum % or its related term are showing as below:

FRA:4QG's 6-1 Month Momentum % is ranked worse than
79.77% of 1473 companies
in the Biotechnology industry
Industry Median: -9.53 vs FRA:4QG: -36.82

Competitive Comparison of PCI Biotech Holding ASA's 6-1 Month Momentum %

For the Biotechnology subindustry, PCI Biotech Holding ASA's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCI Biotech Holding ASA's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's 6-1 Month Momentum % falls into.



PCI Biotech Holding ASA  (FRA:4QG) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PCI Biotech Holding ASA  (FRA:4QG) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


PCI Biotech Holding ASA 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


PCI Biotech Holding ASA Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, N-0379
PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.

PCI Biotech Holding ASA Headlines

No Headlines